{
  "pmcid": "12054398",
  "sha256": "9e6fe70207e4dc967505d14995740b66814de37d2ad46d003dff73e6d7333627",
  "timestamp_utc": "2025-11-09T23:25:09.261974+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 11.970831899024674,
    "reading_ease": 30.356626506024128,
    "word_count": 249
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Intrahematomal Alteplase in Patients with Intraventricular Hemorrhage"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "multicenter randomised controlled trial"
      },
      "Participants": {
        "score": 2,
        "evidence": "included participants with IVH on stability CT scans"
      },
      "Intervention": {
        "score": 2,
        "evidence": "The intervention group received minimally invasive surgery plus alteplase (MIS+alteplase), while the control group received standard medical care (SMC)."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study investigates the impact of intrahematomal alteplase on intraventricular hemorrhage (IVH) volume and functional outcomes in patients with spontaneous intracerebral hemorrhage (ICH)."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the change in IVH volume (deltaIVH) from stability CT to end-of-treatment CT."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, and allocation was concealed."
      },
      "Blinding": {
        "score": 1,
        "evidence": "Outcome assessors were blinded to treatment allocation."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Of 499 patients, 310 had IVH on stability scans; 146 received MIS+alteplase and 164 received SMC."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The MIS+alteplase group showed a greater reduction in IVH volume (deltaIVH: −2.35 mL vs. −1.15 mL, p=0.02). Multivariable linear regression indicated that MIS+alteplase was associated with greater deltaIVH (beta, −0.80; 95%CI, −1.37 to −0.22; p=0.007)."
      },
      "Harms": {
        "score": 0,
        "evidence": "Adverse events were not reported."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 16,
    "max_score": 25
  }
}